Supplementary Figures from Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor–Targeted Therapy Drives Resistance in Breast Cancer
Summary
preprint
Work
Garvan Institute of Medical Research
|Senior Research Officer
Australia
→
University of New South Wales
|Conjoint Lecturer
Australia
→
Garvan Institute of Medical Research
|Research Officer
Australia
→
University of Newcastle
|Research Associate
Australia
→
Education
University of Newcastle
Australia
→
PhD
Universidade Federal do Paraná
Brazil
→
Master
Universidade Federal de Santa Catarina
Brazil
→
Bachelor
Publications
Data from Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor–Targeted Therapy Drives Resistance in Breast Cancer
Summary
preprint
Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor–Targeted Therapy Drives Resistance in Breast Cancer
Published by
Cancer Research
Summary
journal-article
Supplementary Table 3 from Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor–Targeted Therapy Drives Resistance in Breast Cancer
Summary
preprint
Supplementary Table 4 from Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor–Targeted Therapy Drives Resistance in Breast Cancer
Summary
preprint
Supplementary Table 5 from Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor–Targeted Therapy Drives Resistance in Breast Cancer
Summary
preprint
Supplementary Table 6 from Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor–Targeted Therapy Drives Resistance in Breast Cancer
Summary
preprint
Supplementary Table S1 from Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor–Targeted Therapy Drives Resistance in Breast Cancer
Summary
preprint
Supplementary Table S2 from Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor–Targeted Therapy Drives Resistance in Breast Cancer
Summary
preprint
Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-, progesterone-, androgen- and prolactin-receptors in breast cancer
Published by
Pharmacological Research
Summary
journal-article
Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-, progesterone-, androgen- and prolactin-receptors in breast cancer
Published by
Pharmacological Research
Summary
journal-article
Enhancing Metabolite Coverage in MALDI-MSI using Laser Post-Ionisation (MALDI-2).
Summary
preprint
Enhancing Metabolite Coverage in MALDI-MSI using Laser Post-Ionisation (MALDI-2)
Published by
ChemRxiv
Summary
other
An Innovative Non-Hormonal Strategy Targeting Redox Active Metals to Down-Regulate Estrogen-, Progesterone-, Androgen- and Prolactin-Receptors in Breast Cancer
Summary
preprint
An Innovative Non-Hormonal Strategy Targeting Redox Active Metals to Down-Regulate Estrogen-, Progesterone-, Androgen- and Prolactin-Receptors in Breast Cancer
Published by
bioRxiv
Summary
other
Enhancing metabolite coverage in MALDI-MSI using laser post-ionisation (MALDI-2)
Published by
Analytical Methods
Summary
journal-article
Enhancing metabolite coverage in MALDI-MSI using laser post-ionisation (MALDI-2)
Published by
Analytical Methods
Summary
journal-article
Targeting phenotypic plasticity prevents metastasis and the development of chemotherapy-resistant disease
Summary
preprint
Targeting phenotypic plasticity prevents metastasis and the development of chemotherapy-resistant disease
Published by
medRxiv
Summary
other
Epigenetic therapy targets the 3D epigenome in endocrine-resistant breast cancer
Summary
preprint
Epigenetic therapy targets the 3D epigenome in endocrine-resistant breast cancer
Published by
bioRxiv
Summary
other
The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer.
Published by
Nature medicine
Summary
journal-article
The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer
Published by
Nature Medicine
Summary
journal-article
The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer
Published by
Nature Medicine
Summary
journal-article
Differential kynurenine pathway metabolism in highly metastatic aggressive breast cancer subtypes: beyond IDO1-induced immunosuppression.
Published by
Breast cancer research : BCR
Summary
journal-article
Differential kynurenine pathway metabolism in highly metastatic aggressive breast cancer subtypes: beyond IDO1-induced immunosuppression
Published by
Breast Cancer Research
Summary
journal-article
MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer.
Published by
Breast cancer research : BCR
Summary
journal-article
MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer
Published by
Breast Cancer Research
Summary
journal-article
Cyclin E1 and cyclin E2 in ER+ breast cancer: prospects as biomarkers and therapeutic targets.
Published by
Endocrine-related cancer
Summary
journal-article
Cyclin E1 and cyclin E2 in ER+ breast cancer: Prospects as biomarkers and therapeutic targets
Published by
Endocrine-Related Cancer
Summary
journal-article
MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer
Published by
bioRxiv
Summary
other
Non-canonical AR activity facilitates endocrine resistance in breast cancer.
Published by
Endocrine-related cancer
Summary
journal-article
Non-canonical AR activity facilitates endocrine resistance in breast cancer
Published by
Endocrine-Related Cancer
Summary
journal-article
Basal-like breast cancer: molecular profiles, clinical features and survival outcomes.
Published by
BMC medical genomics
Summary
journal-article
Basal-like breast cancer: molecular profiles, clinical features and survival outcomes
Published by
BMC Medical Genomics
Summary
journal-article
Extensive Transcriptomic and Genomic Analysis Provides New Insights about Luminal Breast Cancers.
Published by
PloS one
Summary
journal-article
Extensive transcriptomic and genomic analysis provides new insights about luminal breast cancers
Published by
PLoS ONE
Summary
journal-article
Life as an early career researcher: interview with Heloisa Helena Milioli.
Published by
Future science OA
Summary
journal-article
Life as an early career researcher: Interview with Heloisa Helena Milioli
Published by
Future Science OA
Summary
journal-article
Comparative proteomic analysis of ductal and lobular invasive breast carcinoma.
Published by
Genetics and molecular research : GMR
Summary
journal-article
Comparative proteomic analysis of ductal and lobular invasive breast carcinoma
Published by
Genetics and Molecular Research
Summary
journal-article
Iteratively refining breast cancer intrinsic subtypes in the METABRIC dataset.
Published by
BioData mining
Summary
journal-article
Iteratively refining breast cancer intrinsic subtypes in the METABRIC dataset
Published by
BioData Mining
Summary
journal-article
The IMPAKT of breast cancer research: fundamental science and applied medicine.
Published by
Future science OA
Summary
journal-article
The IMPAKT of breast cancer research: Fundamental science and applied medicine
Published by
Future Science OA
Summary
journal-article
The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.
Published by
PloS one
Summary
journal-article
The discovery of novel biomarkers improves breast cancer intrinsic subtype prediction and reconciles the labels in the METABRIC data set
Published by
PLoS ONE
Summary
journal-article
Comparative proteomics of primary breast carcinomas and lymph node metastases outlining markers of tumor invasion.
Published by
Cancer genomics & proteomics
Summary
journal-article
Comparative proteomics of primary breast carcinomas and lymph node metastases outlining markers of tumor invasion
Published by
Cancer Genomics and Proteomics
Summary
journal-article